Researchers concluded that a subgroup of [Alzheimers] patients aged 65 or younger may benefit from treatment with [ALCAR] whereas older individuals might do more poorly. 13 A follow up study reanalyzed the results and came to similar conclusions, suggesting that ALCAR slows the progression of Alzheimers disease in younger subjects. 14 In another follow-up study that compared ALCARs effect on those with early-onset (age 45-65) and regular Alzheimers, researchers reached a different conclusion, reporting that there were no significant differences between the treatment groups. 15 ALCAR 1,500 mg seems to help with depression in the elderly In this study, 28 elderly patients aged 70-80 who had been diagnosed with depression were given either 1,500 mg Acetyl-L-Carnitine or placebo daily, and were then evaluated with three cognitive tests and by clinical observation
In a recent study, the administration of HDAC inhibitors in combination with curcumin enhances the impact of the phytoconstituent compound
Immunomodulatory effects of the triterpenoid CDDO after allogeneic bone marrow transplantation in mice: reduction of acute graft-versus-host disease lethality
MPTP mouse models of Parkinsons disease: an update
In this study, we used the definitive diagnostic criteria for destructive thyroiditis, hyperthyroidism and hypothyroidism established by the Japan Thyroid Association
Net weight of product: 86 g
